MCD Form 144 lists 10b5-1 sales by Joseph Erlinger

MCD reports Form 144 sales by Joseph Erlinger.

Accepted by SEC EDGAR 04/23/2026 - 04:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MCD reports Form 144 sales by Joseph Erlinger. The filing lists multiple 10b5-1 sales of Common stock executed on 02/10/2026, 02/23/2026, 03/10/2026, 03/23/2026, and 04/10/2026 with individual share counts and gross proceeds shown.

The excerpt also records a grant of Performance Restricted Stock Units dated 02/13/2026 and identifies Morgan Stanley Smith Barney LLC as the broker.

Key Figures

Shares sold on 04/10/2026: 2,626 shares Proceeds on 04/10/2026: $806,182.00 Shares sold on 03/10/2026: 2,626 shares +2 more

5 metrics

Shares sold on 04/10/2026 2,626 shares 10b5-1 sale by Joseph Erlinger on <date>04/10/2026</date>

Proceeds on 04/10/2026 $806,182.00 Gross proceeds reported for 2,626-share sale on <date>04/10/2026</date>

Shares sold on 03/10/2026 2,626 shares 10b5-1 sale by Joseph Erlinger on <date>03/10/2026</date>

Proceeds on 03/10/2026 $862,220.84 Gross proceeds reported for 2,626-share sale on <date>03/10/2026</date>

PRSU grant date and amount 333 shares Performance Restricted Stock Units grant dated <date>02/13/2026</date>

Key Terms

10b5-1, Form 144, Performance Restricted Stock Units, Gross proceeds

4 terms

10b5-1 regulatory

"10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Restricted Stock Units financial

"Performance Restricted Stock Units | Issuer | 333 | 02/13/2026"

Performance restricted stock units (PRSUs) are promises to deliver company shares to employees or executives only if the business meets specific performance targets and any time-based holding rules. Think of them as a bonus that converts into stock only after set goals are reached, so investors watch PRSUs for two reasons: they can dilute existing shares if paid out, and they signal how closely management’s pay is tied to company performance.

Gross proceeds financial

"2626 | 806182.00"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MCD Form 144 disclose about Joseph Erlinger?

It discloses multiple 10b5-1 sales by Joseph Erlinger on specific dates with share counts and gross proceeds. The filing lists transactions on 02/10/2026, 02/23/2026, 03/10/2026, 03/23/2026, and 04/10/2026.

How many shares were sold on April 10, 2026 in the MCD filing?

The filing shows 2,626 shares sold on 04/10/2026 under a 10b5-1 plan, with gross proceeds reported as $806,182.00. This line appears verbatim in the excerpt’s sales table.

Was any equity awarded to Joseph Erlinger shown in the filing?

Yes. The excerpt shows a grant of Performance Restricted Stock Units dated 02/13/2026 consisting of 333 shares listed under securities to be sold. The grant line is present in the securities section.

Which broker handled the sales listed in the MCD Form 144?

The filing identifies Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker for the transactions. That broker name and address appear in the securities/broker section of the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001685800
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	McDONALDs CORPORATION
SEC File Number	001-05231
Address of Issuer	110 North Carpenter Street Chicago ILLINOIS 60607
Phone	6306233000
Name of Person for Whose Account the Securities are To Be Sold	JOSEPH ERLINGER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	333	99923.31	710398642	04/23/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/13/2026	Performance Restricted Stock Units	Issuer			333	02/13/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	04/10/2026	2626	806182.00
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	03/23/2026	333	104385.51
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	03/10/2026	2626	862220.84
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	02/23/2026	333	110033.19
10b5-1 Sales for JOSEPH ERLINGER 110 North Carpenter Street Chicago IL 60607	Common	02/10/2026	2626	854106.50

144: Remarks and Signature

Remarks
Date of Notice	04/23/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/07/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joe Erlinger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)